000			02207 a2200661 4500
005			20250515222925.0
264		0	_c20110120
008			201101s 0 0 eng d
022			_a1878-0210
024	7		_a10.1016/j.pcd.2010.04.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aGundgaard, Jens
245	0	0	_aDirect healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen. _h[electronic resource]
260			_bPrimary care diabetes _cOct 2010
300			_a165-72 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAmbulatory Care _xeconomics
650	0	4	_aChi-Square Distribution
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCost-Benefit Analysis
650	0	4	_aDenmark
650	0	4	_aDiabetes Mellitus, Type 2 _xdrug therapy
650	0	4	_aDrug Costs
650	0	4	_aFemale
650	0	4	_aGeneral Practice _xeconomics
650	0	4	_aHealth Care Costs
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xeconomics
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aInsulin _xanalogs & derivatives
650	0	4	_aInsulin Detemir
650	0	4	_aInsulin Glargine
650	0	4	_aInsulin, Isophane _xeconomics
650	0	4	_aInsulin, Long-Acting
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMetformin _xeconomics
650	0	4	_aMiddle Aged
650	0	4	_aModels, Economic
650	0	4	_aOdds Ratio
650	0	4	_aOutcome and Process Assessment, Health Care _xeconomics
650	0	4	_aPharmaceutical Services _xeconomics
650	0	4	_aPrimary Health Care _xeconomics
650	0	4	_aPropensity Score
650	0	4	_aReferral and Consultation _xeconomics
650	0	4	_aRegistries
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aChristensen, Torsten E
700	1		_aThomsen, Trine Lyager
773	0		_tPrimary care diabetes _gvol. 4 _gno. 3 _gp. 165-72
856	4	0	_uhttps://doi.org/10.1016/j.pcd.2010.04.004 _zAvailable from publisher's website
999			_c19808177 _d19808177